460 related articles for article (PubMed ID: 26459647)
1. Outpatient Visits and Medication Prescribing for US Children With Mental Health Conditions.
Anderson LE; Chen ML; Perrin JM; Van Cleave J
Pediatrics; 2015 Nov; 136(5):e1178-85. PubMed ID: 26459647
[TBL] [Abstract][Full Text] [Related]
2. Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness.
Harpaz-Rotem I; Rosenheck RA
Child Care Health Dev; 2006 Mar; 32(2):225-37. PubMed ID: 16441857
[TBL] [Abstract][Full Text] [Related]
3. Care Provision and Prescribing Practices of Physicians Treating Children and Adolescents With ADHD.
Patel A; Medhekar R; Ochoa-Perez M; Aparasu RR; Chan W; Sherer JT; Alonzo J; Chen H
Psychiatr Serv; 2017 Jul; 68(7):681-688. PubMed ID: 28196459
[TBL] [Abstract][Full Text] [Related]
4. Variations in Mental Health Diagnosis and Prescribing Across Pediatric Primary Care Practices.
Mayne SL; Ross ME; Song L; McCarn B; Steffes J; Liu W; Margolis B; Azuine R; Gotlieb E; Grundmeier RW; Leslie LK; Localio R; Wasserman R; Fiks AG
Pediatrics; 2016 May; 137(5):. PubMed ID: 27244791
[TBL] [Abstract][Full Text] [Related]
5. Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder.
Zito JM; Safer DJ; dosReis S; Magder LS; Gardner JF; Zarin DA
Arch Pediatr Adolesc Med; 1999 Dec; 153(12):1257-63. PubMed ID: 10591302
[TBL] [Abstract][Full Text] [Related]
6. Medication patterns for attention-deficit/hyperactivity disorder and comorbid psychiatric conditions in a low-income population.
Radigan M; Lannon P; Roohan P; Gesten F
J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):44-56. PubMed ID: 15741785
[TBL] [Abstract][Full Text] [Related]
7. Determinants of initial pharmacological treatment for youths with attention-deficit/hyperactivity disorder.
Chen CY; Gerhard T; Winterstein AG
J Child Adolesc Psychopharmacol; 2009 Apr; 19(2):187-95. PubMed ID: 19364296
[TBL] [Abstract][Full Text] [Related]
8. Pediatricians' role in providing mental health care for children and adolescents: do pediatricians and child and adolescent psychiatrists agree?
Heneghan A; Garner AS; Storfer-Isser A; Kortepeter K; Stein RE; Horwitz SM
J Dev Behav Pediatr; 2008 Aug; 29(4):262-9. PubMed ID: 18698191
[TBL] [Abstract][Full Text] [Related]
9. Physician Office Visits for Attention-deficit/Hyperactivity Disorder in Children and Adolescents Aged 4-17 Years: United States, 2012-2013.
Albert M; Rui P; Ashman JJ
NCHS Data Brief; 2017 Jan; (269):1-8. PubMed ID: 28135186
[TBL] [Abstract][Full Text] [Related]
10. National trends in child and adolescent psychotropic polypharmacy in office-based practice, 1996-2007.
Comer JS; Olfson M; Mojtabai R
J Am Acad Child Adolesc Psychiatry; 2010 Oct; 49(10):1001-10. PubMed ID: 20855045
[TBL] [Abstract][Full Text] [Related]
11. For what diagnoses are psychotropic medications being prescribed?: a nationally representative survey of physicians.
Mark TL
CNS Drugs; 2010 Apr; 24(4):319-26. PubMed ID: 20297856
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics.
Bussing R; Narwaney KJ; Winterstein AG; Newton DA; DeBar L; Boscarino JA; Toh S; Pawloski P; Nordin JD; Herrinton LJ; Mason D; Daley MF
Curr Med Res Opin; 2014 Aug; 30(8):1687-99. PubMed ID: 24635013
[TBL] [Abstract][Full Text] [Related]
13. Pharmacotherapy for the treatment of aggression in pediatric and adolescent patients with autism spectrum disorder comorbid with attention-deficit hyperactivity disorder: A questionnaire survey of 571 psychiatrists.
Yamamuro K; Tsujii N; Ota T; Kishimoto T; Iida J
Psychiatry Clin Neurosci; 2017 Aug; 71(8):554-561. PubMed ID: 28317224
[TBL] [Abstract][Full Text] [Related]
14. Medication management of stimulants in pediatric practice settings: a national perspective.
Hoagwood K; Jensen PS; Feil M; Vitiello B; Bhatara VS
J Dev Behav Pediatr; 2000 Oct; 21(5):322-31. PubMed ID: 11064959
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric medication preferences of sports psychiatrists.
Reardon CL; Creado S
Phys Sportsmed; 2016 Nov; 44(4):397-402. PubMed ID: 27463033
[TBL] [Abstract][Full Text] [Related]
17. Aligning clinical practice to PTSD treatment guidelines: medication prescribing by provider type.
Abrams TE; Lund BC; Bernardy NC; Friedman MJ
Psychiatr Serv; 2013 Feb; 64(2):142-8. PubMed ID: 23474508
[TBL] [Abstract][Full Text] [Related]
18. Pharmacotherapy with atomoxetine for US children and adolescents.
Bhatara VS; Aparasu RR
Ann Clin Psychiatry; 2007; 19(3):175-80. PubMed ID: 17729019
[TBL] [Abstract][Full Text] [Related]
19. Psychotropic medication patterns among youth in foster care.
Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
[TBL] [Abstract][Full Text] [Related]
20. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM; Earls MF
Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
